BRPI0822980A2 - Método de fabricação de tabuleta - Google Patents
Método de fabricação de tabuletaInfo
- Publication number
- BRPI0822980A2 BRPI0822980A2 BRPI0822980-5A BRPI0822980A BRPI0822980A2 BR PI0822980 A2 BRPI0822980 A2 BR PI0822980A2 BR PI0822980 A BRPI0822980 A BR PI0822980A BR PI0822980 A2 BRPI0822980 A2 BR PI0822980A2
- Authority
- BR
- Brazil
- Prior art keywords
- signboard
- making method
- making
- signboard making
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/NZ2008/000190 WO2010014015A1 (en) | 2008-07-29 | 2008-07-29 | Tablet manufacturing method |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0822980A2 true BRPI0822980A2 (pt) | 2015-06-23 |
Family
ID=41610570
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0822980-5A BRPI0822980A2 (pt) | 2008-07-29 | 2008-07-29 | Método de fabricação de tabuleta |
Country Status (4)
Country | Link |
---|---|
AU (1) | AU2008360070B2 (pt) |
BR (1) | BRPI0822980A2 (pt) |
WO (1) | WO2010014015A1 (pt) |
ZA (1) | ZA201101565B (pt) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103919745B (zh) * | 2014-05-08 | 2017-01-11 | 成都乾坤动物药业有限公司 | 兽用苯并咪唑类着色驱虫药物配方及其工艺 |
WO2018038623A1 (en) * | 2016-08-23 | 2018-03-01 | Donaghys Limited | Improvements in parasite treatments |
CN111067875B (zh) * | 2020-01-16 | 2021-11-30 | 兰州大学 | 一种阿苯达唑液固压缩片及其制备方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU772988B2 (en) * | 1999-06-04 | 2004-05-13 | Elanco Tiergesundheit Ag | Stable biocidal compositions |
US20040151759A1 (en) * | 2002-08-16 | 2004-08-05 | Douglas Cleverly | Non-animal product containing veterinary formulations |
US7396819B2 (en) * | 2003-08-08 | 2008-07-08 | Virbac Corporation | Anthelmintic formulations |
US7582612B2 (en) * | 2004-03-12 | 2009-09-01 | Hartz Mountain Corporation | Multi-action anthelmintic formulations |
AU2005232685A1 (en) * | 2004-04-07 | 2005-10-27 | Intervet International B.V. | Efficacious composition of a benzimidazole, an avermectin and praziquantel and related methods of use |
NZ552293A (en) * | 2006-12-21 | 2009-03-31 | Bomac Research Ltd | Tablet formulation comprising a macrocyclic lactone and a levamisole compound having anthelmintic activity |
NZ552290A (en) * | 2006-12-21 | 2009-05-31 | Bomac Research Ltd | Tablet fomulation |
-
2008
- 2008-07-29 BR BRPI0822980-5A patent/BRPI0822980A2/pt not_active Application Discontinuation
- 2008-07-29 AU AU2008360070A patent/AU2008360070B2/en not_active Withdrawn - After Issue
- 2008-07-29 WO PCT/NZ2008/000190 patent/WO2010014015A1/en active Application Filing
-
2011
- 2011-02-28 ZA ZA2011/01565A patent/ZA201101565B/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU2008360070A1 (en) | 2010-02-04 |
ZA201101565B (en) | 2015-10-28 |
WO2010014015A1 (en) | 2010-02-04 |
AU2008360070B2 (en) | 2015-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0919116A2 (pt) | método | |
BRPI0814359A2 (pt) | Método | |
BRPI0817226A2 (pt) | Método | |
BRPI0817726A2 (pt) | Método | |
BR112012004707A2 (pt) | método | |
BR112012000624A2 (pt) | método | |
FI20090389A0 (fi) | Menetelmä | |
DK2313489T3 (da) | Fremstillingsmetode | |
BRPI0920540A2 (pt) | método de produção de álcool | |
BRPI1012526A2 (pt) | método | |
BRPI0817667A2 (pt) | Método de marcação | |
BRPI1010705A2 (pt) | método | |
BRPI0920140A2 (pt) | método de floculação | |
BRPI0918857A2 (pt) | método de produção de poliamida | |
BRPI0909816A2 (pt) | método de escaneamento | |
BRPI0911625A2 (pt) | Métodos | |
BRPI1012532A2 (pt) | método | |
BRPI0810416A2 (pt) | Método de hidroformação | |
BRPI0911364A2 (pt) | tienopirimidinas | |
BRPI0916597A2 (pt) | Método | |
BRPI1009350A2 (pt) | método | |
BRPI0910255A2 (pt) | método de escaneamento | |
BRPI0915125A2 (pt) | método de seleção ii | |
BRPI0815419A2 (pt) | Método de produção | |
IT1394172B1 (it) | Metodo prognostico |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 3A, 4A, 5A, 6A E 7A ANUIDADES. |
|
B06G | Technical and formal requirements: other requirements [chapter 6.7 patent gazette] |
Free format text: PARA QUE SEJA ACEITA A PETICAO 020150017974 DE 22/12/2015, O INTERESSADO DEVERA COMPROVAR O RECOLHIMENTO DA 3A E 7A ANUIDADE(S) NO PRAZO EXTRAORDINARIO. UMA VEZ QUE A GRU REFERENTE A 3A ANUIDADE(S), APRESENTADA NA PETICAO SUPRACITADA, SE REFERE AO PI 0008964-8 E A GRU REFERENTE A 7A ANUIDADE (S) FOI RECOLHIDA ANTECIPADAMENTE, ESTANDO EM DESACORDO COM A RESOLUCAO 113/13, ARTIGO 3A. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] | ||
B25A | Requested transfer of rights approved |
Owner name: BAYER NEW ZEALAND LIMITED (NZ) |
|
B08H | Application fees: decision cancelled [chapter 8.8 patent gazette] | ||
B06I | Publication of requirement cancelled [chapter 6.9 patent gazette] | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
B08G | Application fees: restoration [chapter 8.7 patent gazette] | ||
B15G | Petition not considered as such [chapter 15.7 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07G | Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette] | ||
B06I | Publication of requirement cancelled [chapter 6.9 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL. |